Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Kim

Showing results (171-180 of 209) with videos related to

Pageof 21
Sort By:
Plos One|December 29, 2010
The nuclear inclusion a (NIa) protease of turnip mosaic virus (TuMV) cleaves amyloid-βHye-Eun Han, Saravanan Sellamuthu, Bae Hyun Shin, et al.
Gynecologic Oncology|January 20, 2020
Hormone receptor expression and outcomes in low-grade serous ovarian carcinomaMarta Llaurado Fernandez, Amy Dawson, Hannah Kim, et al.
Science Advances|September 26, 2025
Nanomedicine targeting PPAR in adipose tissue macrophages improves lipid metabolism and obesity-induced metabolic dysfunctionCatherine C Applegate, Yifei Kang, Hongping Deng, et al.
The Journal of Pediatrics|June 15, 2026
Ambulatory Blood Pressure Thresholds and Left Ventricular Hypertrophy in Children Aged 6-12 Years: A Pediatric Nephrology Research Consortium StudyAfsana Jahan, Matthew Schuchman, Mahie Abdullah, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Journal of Gynecologic Oncology|March 28, 2025
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinomaYuen Yee Leung, Marta Llaurado-Fernandez, Anna Cameron, et al.
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironmentYu Wang, Bryan Duong, Sam Keeley, et al.
The Oncologist|July 26, 2021
Association Between Caregiver-Oncologist Discordance in Patient's Life Expectancy Estimates and Caregiver Perceived Autonomy Support by the OncologistGina Tuch, Chandrika Sanapala, Supriya G Mohile, et al.
Gynecologic Oncology|July 6, 2024
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancerPooja Praveen Kumar, DuPreez Smith, James Key, et al.
Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
Plos One|December 29, 2010
The nuclear inclusion a (NIa) protease of turnip mosaic virus (TuMV) cleaves amyloid-βHye-Eun Han, Saravanan Sellamuthu, Bae Hyun Shin, et al.
Gynecologic Oncology|January 20, 2020
Hormone receptor expression and outcomes in low-grade serous ovarian carcinomaMarta Llaurado Fernandez, Amy Dawson, Hannah Kim, et al.
Science Advances|September 26, 2025
Nanomedicine targeting PPAR in adipose tissue macrophages improves lipid metabolism and obesity-induced metabolic dysfunctionCatherine C Applegate, Yifei Kang, Hongping Deng, et al.
The Journal of Pediatrics|June 15, 2026
Ambulatory Blood Pressure Thresholds and Left Ventricular Hypertrophy in Children Aged 6-12 Years: A Pediatric Nephrology Research Consortium StudyAfsana Jahan, Matthew Schuchman, Mahie Abdullah, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Journal of Gynecologic Oncology|March 28, 2025
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinomaYuen Yee Leung, Marta Llaurado-Fernandez, Anna Cameron, et al.
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironmentYu Wang, Bryan Duong, Sam Keeley, et al.
The Oncologist|July 26, 2021
Association Between Caregiver-Oncologist Discordance in Patient's Life Expectancy Estimates and Caregiver Perceived Autonomy Support by the OncologistGina Tuch, Chandrika Sanapala, Supriya G Mohile, et al.
Gynecologic Oncology|July 6, 2024
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancerPooja Praveen Kumar, DuPreez Smith, James Key, et al.
Pageof 21